Cigna Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$542K Sell
1,032
-20
-2% -$10.5K 0.09% 212
2025
Q1
$667K Sell
1,052
-26
-2% -$16.5K 0.12% 168
2024
Q4
$768K Sell
1,078
-9
-0.8% -$6.41K 0.13% 150
2024
Q3
$1.14M Sell
1,087
-15
-1% -$15.8K 0.2% 97
2024
Q2
$1.16M Buy
1,102
+6
+0.5% +$6.31K 0.21% 92
2024
Q1
$1.06M Sell
1,096
-6
-0.5% -$5.78K 0.2% 108
2023
Q4
$967K Sell
1,102
-17
-2% -$14.9K 0.2% 113
2023
Q3
$921K Sell
1,119
-158
-12% -$130K 0.21% 102
2023
Q2
$918K Buy
1,277
+5
+0.4% +$3.59K 0.17% 119
2023
Q1
$1.05M Sell
1,272
-26
-2% -$21.4K 0.21% 104
2022
Q4
$937K Buy
1,298
+4
+0.3% +$2.89K 0.19% 114
2022
Q3
$891K Sell
1,294
-55
-4% -$37.9K 0.2% 106
2022
Q2
$798K Sell
1,349
-489
-27% -$289K 0.16% 136
2022
Q1
$1.28M Sell
1,838
-533
-22% -$372K 0.16% 125
2021
Q4
$1.5M Sell
2,371
-862
-27% -$545K 0.12% 137
2021
Q3
$1.96M Sell
3,233
-111
-3% -$67.2K 0.15% 127
2021
Q2
$1.87M Sell
3,344
-403
-11% -$225K 0.13% 136
2021
Q1
$1.77M Buy
3,747
+21
+0.6% +$9.94K 0.12% 151
2020
Q4
$1.8M Buy
3,726
+382
+11% +$185K 0.14% 138
2020
Q3
$1.87M Sell
3,344
-30
-0.9% -$16.8K 0.18% 109
2020
Q2
$2.1M Buy
3,374
+1,032
+44% +$644K 0.2% 99
2020
Q1
$1.14M Buy
2,342
+150
+7% +$73.3K 0.15% 155
2019
Q4
$741K Sell
2,192
-222
-9% -$75K 0.08% 292
2019
Q3
$739K Buy
2,414
+100
+4% +$30.6K 0.08% 301
2019
Q2
$705K Sell
2,314
-70
-3% -$21.3K 0.08% 298
2019
Q1
$978K Buy
2,384
+19
+0.8% +$7.79K 0.11% 237
2018
Q4
$883K Sell
2,365
-60
-2% -$22.4K 0.07% 194
2018
Q3
$822K Sell
2,425
-123
-5% -$41.7K 0.07% 229
2018
Q2
$879K Sell
2,548
-392
-13% -$135K 0.06% 268
2018
Q1
$1.01M Sell
2,940
-61
-2% -$21K 0.07% 253
2017
Q4
$1.13M Sell
3,001
-114
-4% -$42.9K 0.07% 222
2017
Q3
$1.39M Buy
3,115
+74
+2% +$33.1K 0.09% 167
2017
Q2
$1.49M Sell
3,041
-156
-5% -$76.6K 0.1% 154
2017
Q1
$1.24M Buy
3,197
+356
+13% +$138K 0.09% 218
2016
Q4
$1.04M Buy
+2,841
New +$1.04M 0.11% 229